Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

Honey, I Shrunk the Molecules

| Jamie Irvine | 2 min read

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Discovery & Development Drug Discovery

Lonely Hearts Club

| Jamie Irvine | 4 min read

TUM Researchers create organoid that emulates the development of the human heart

Discovery & Development Drug Discovery

Afraid of Banality, Driven by Beauty

| 5 min read

Sitting Down With … Tirtha Chakraborty, Chief Scientific Officer at Vor Bio

Discovery & Development Drug Discovery

Anti-Anxiety

| Jamie Irvine | 4 min read

Researchers identify brain pathway – miR483-5p/Pgap2 – that holds promise for future anxiety treatments

Discovery & Development Drug Discovery

Expanding Targets for ADCs

| Marwan Alsarraj | 2 min read

Adcendo signs antibody drug conjugate licensing deal with DualityBio.

Discovery & Development Drug Discovery

The PEPITEM Pathway – and the Path to New Obesity Treatments

| Stephanie Vine | 6 min read

The world needs new medicines to treat obesity-related conditions. Here’s what researchers at the UK’s University of Birmingham are doing about it.

Discovery & Development Drug Discovery

Tracing the Origins of Antibiotic Resistance

| Jamie Irvine | 5 min read

Improved mutational understanding may help develop therapeutics against antimicrobial resistance

Discovery & Development Advanced Medicine

Video Interview: Phil Vanek on the Importance of Regulatory Harmonization

| Stephanie Vine

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

Discovery & Development Drug Discovery

A Call to Arms for Antimicrobial Resistance

| Peter Jackson | 13 min read

Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price.

Discovery & Development Drug Delivery

Semaglutide Versus AUD

| Jamie Irvine | 4 min read

Swedish researchers target the brain’s reward system to treat alcohol use disorder

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register